Patent details

EP3279335 Title: HIGHLY SENSITIVE CELL-BASED ASSAY TO DETECT THE PRESENCE OF ACTIVE BOTULINUM NEUROTOXIN SEROTYPE-A

Basic Information

Publication number:
EP3279335
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP171780620
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HIGHLY SENSITIVE CELL-BASED ASSAY TO DETECT THE PRESENCE OF ACTIVE BOTULINUM NEUROTOXIN SEROTYPE-A
French Title of Invention:
DOSAGE CELLULAIRE EXTRÊMEMENT SENSIBLE POUR DÉTECTER LA PRÉSENCE D'UNE NEUROTOXINE ACTIVE BOTULIQUE DE SÉROTYPE A
German Title of Invention:
HOCHEMPFINDLICHER ZELLBASIERTER TEST FÜR DEN NACHWEIS DER ANWESENHEIT VON AKTIVEM BOTULINUM-NEUROTOXIN-SEROTYP-A
SPC Number:

Dates

Filing date:
28/12/2012
Grant date:
10/03/2021
EP Publication Date:
07/02/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/03/2021
EP B1 Publication Date:
10/03/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/12/2021
Expiration date:
28/12/2032
Renunciation date:
Revocation date:
13/05/2022
Annulment date:

Owner

From:
03/03/2021
 
 

Name:
ALLERGAN, INC.
Address:
2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

1

Name:
Gupta, Swati
Address:
United States (US)

2

Name:
Dixit, Anuradha
Address:
United States (US)

3

Name:
Abel, Kenton
Address:
United States (US)

4

Name:
Fernandez-Salas, Ester
Address:
United States (US)

5

Name:
Wang, Joanne
Address:
United States (US)

Priority

Priority Number:
201161582339 P
Priority Date:
31/12/2011
Priority Country:
United States (US)

Classification

IPC classification:
C12Q 1/37; G01N 33/569; G01N 33/573;

Publication

European Patent Bulletin

1

Issue number:
202110
Publication date:
10/03/2021
Description:
Grant (B1)

2

Issue number:
202202
Publication date:
12/01/2022
Description:
Opposition procedure started

3

Issue number:
202238
Publication date:
21/09/2022
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages